Cargando…

Optimal timing of rest perfusion with regadenoson stress testing - normal volunteer study of quantitative MRI perfusion

Detalles Bibliográficos
Autores principales:	Vasu, Sujethra, Bandettini, W Patricia, Hsu, Li-Yueh, Kellman, Peter, Wilson, Joel, Leung, Steve, Shanbhag, Sujata M, Booker, O Julian, Mancini, Christine, Henry, Jennifer, Lowrey, Tracy, Arai, Andrew E
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106570/ http://dx.doi.org/10.1186/1532-429X-13-S1-P128

Ejemplares similares

Impaired coronary vasodilation with Regadenoson in patients with angiographically normal coronaries when compared to normal volunteers - Insights from Quantitative MRI Perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Regadenoson is a better myocardial vasodilator than dipyridamole in normal volunteers, but the data is less compelling in patients
por: Vasu, Sujethra, et al.
Publicado: (2011)

Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance
por: Vasu, Sujethra, et al.
Publicado: (2013)

Time resolved measure of coronary sinus flow following regadenoson administration
por: Booker, O Julian, et al.
Publicado: (2011)

Heterogeneity of resting and hyperemic myocardial blood flow in healthy volunteers: a quantitative CMR perfusion pixel-map study
por: Greve, Anders M, et al.
Publicado: (2014)

In the absence of obstructive coronary artery disease, patients with class II and III obesity have decreased myocardial perfusion reserve
por: Bandettini, W Patricia, et al.
Publicado: (2014)

Safety and tolerability of regadenoson CMR
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

Feasibility and preliminary diagnostic results of pixel-wise quantification of regadenoson first pass cardiac magnetic resonance perfusion imaging
por: Ta, Allison D, et al.
Publicado: (2014)

MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study
por: Bandettini, W Patricia, et al.
Publicado: (2012)

Concordance and diagnostic accuracy of vasodilator stress cardiac MRI and 320-detector row coronary CTA
por: Chen, Marcus Y., et al.
Publicado: (2013)

Image quality and diagnostic accuracy of inline motion-corrected (moco) first-pass stress myocardial perfusion images
por: Shanbhag, Sujata M, et al.
Publicado: (2011)

Regadenoson stress induced wall motion abnormalities during cardiac MRI
por: Parikh, Kalindi, et al.
Publicado: (2015)

Interobserver reproducibility of fully quantitative pixel-wise analysis of clinical CMR perfusion imaging
por: Conn, Hannah, et al.
Publicado: (2014)

Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance
por: Freed, Benjamin H, et al.
Publicado: (2013)

Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium
por: Allen, Bradley D, et al.
Publicado: (2015)

Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
por: Radwan, Sohab S., et al.
Publicado: (2019)

Fully quantitative pixel-wise analysis of cardiovascular magnetic resonance perfusion improves discrimination of dark rim artifact from perfusion defects associated with epicardial coronary stenosis
por: Ta, Allison D., et al.
Publicado: (2018)

Serious complications associated with regadenoson administration for myocardial perfusion imaging
por: Kitt, Therese, et al.
Publicado: (2014)

Severe Shivering as an Adverse Effect of Regadenoson Myocardial Perfusion Imaging
por: Ahmad, Tanjeev, et al.
Publicado: (2021)

Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR
por: Muñiz-Sáenz-Diez, Javier, et al.
Publicado: (2023)

Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy
por: Brinkert, M., et al.
Publicado: (2013)

Regadenoson in Myocardial Perfusion Study - First Institutional Experiences in Bosnia and Herzegovina
por: Beslic, Nermina, et al.
Publicado: (2016)

Initial results of a new very rapid rest/regadenoson stress myocardial perfusion protocol in patients with atrial fibrillation
por: Chang, Lowell, et al.
Publicado: (2014)

Diagnostic Performance of Fully Automated Pixel-Wise Quantitative Myocardial Perfusion Imaging by Cardiovascular Magnetic Resonance
por: Hsu, Li-Yueh, et al.
Publicado: (2018)

Comparison of Regadenoson and Dipyridamole Safety Profiles During Stress Myocardial Perfusion Imaging
por: Roczniak, Jan, et al.
Publicado: (2023)

Impact of errors in determining the start of myocardial enhancement during quantitative first pass perfusion cardiovascular magnetic resonance imaging
por: Ta, Allison D, et al.
Publicado: (2014)

Mechanisms for overestimating acute myocardial infarct size with gadolinium-enhanced cardiovascular magnetic resonance imaging in humans: a quantitative and kinetic study(†)
por: Hammer-Hansen, Sophia, et al.
Publicado: (2016)

Regadenoson cardiovascular magnetic resonance myocardial perfusion imaging predicts need for future revascularization
por: Freed, Benjamin H, et al.
Publicado: (2012)

Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson
por: Bhave, Nicole M, et al.
Publicado: (2012)

Cardiovascular effects and tolerance of adenosine versus regadenoson during cardiac MRI perfusion testing
por: Minor, Matthew, et al.
Publicado: (2015)

Regadenoson administration and QT interval prolongation during pharmacological radionuclide myocardial perfusion imaging
por: Rafiq, Arsalan, et al.
Publicado: (2020)

Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
por: Kero, Tanja, et al.
Publicado: (2021)

Editorial: Regadenoson: An adenosine A(2A) receptor agonist for pharmacological myocardial perfusion imaging
por: Matsuo, Shinro
Publicado: (2014)

Safety and Efficacy of Regadenoson for Pediatric Stress Perfusion Cardiac MRI with Quantification of Myocardial Blood Flow
por: Patel, Shivani G., et al.
Publicado: (2022)

Automatic per-segment analysis of myocardial perfusion MRI
por: Jolly, Marie-Pierre, et al.
Publicado: (2011)

Clinical impact of cardiovascular magnetic resonance in evaluation for possible arrhythmogenic right ventricular dysplasia/cardiomyopathy
por: Choi, Andrew D, et al.
Publicado: (2015)

FLASH proton density imaging for improved surface coil intensity correction in quantitative and semi-quantitative SSFP perfusion cardiovascular magnetic resonance
por: Nielles-Vallespin, Sonia, et al.
Publicado: (2015)

Characterization of cardiac masses with T1 mapping
por: Saba, Shahryar G, et al.
Publicado: (2015)

Determinants of myocardial perfusion reserve measured from coronary sinus phase-contrast imaging during regadenoson stress CMR
por: Bauml, Michael A, et al.
Publicado: (2014)

Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study
por: Tejani, Furqan H., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_polb5567elk1ksju0lhcjm9abg